Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)
Titel:
Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)
Auteur:
Takeda, K. Negoro, S. Tamura, T. Nishiwaki, Y. Kudoh, S. Yokota, S. Matsui, K. Semba, H. Nakagawa, K. Takada, Y. Ando, M. Shibata, T. Saijo, N.